Literature DB >> 26852686

Multiple pathways regulate Cten in colorectal cancer without a Tensin switch.

Hannah Thorpe1, Maham Akhlaq1, Darryl Jackson1, Saleh Al Ghamdi2, Sarah Storr1, Stewart Martin1, Mohammad Ilyas1.   

Abstract

CTEN/TNS4 is a member of the Tensin gene family. It localizes to focal adhesions and induces cell motility. The mechanisms regulating Cten expression are unclear although we have shown regulation by Kras in the colon and pancreas. In normal mammary cell lines, it is reportedly upregulated by epidermal growth factor receptor (EGFR) and STAT3 signalling and upregulation is accompanied by downregulation of Tensin 3 (Tensin switch). In this study, we investigated the roles of EGFR and STAT3 signalling in the regulation of Cten in colorectal cancer (CRC). In addition, we investigated calpain--a regulator of focal adhesion-associated proteins whose relevance to Cten has not been investigated. CRC cell lines were stimulated with epidermal growth factor (EGF). This resulted in an increase in Cten and Tensin 3 protein. Kras was knocked down and this resulted in downregulation of Cten and Tensin 3. We next investigated the role of STAT3 signalling. Activation and knockdown of STAT3 resulted in downregulation and upregulation, respectively, of Cten. Inhibition of calpain resulted in upregulation of both Cten and Tensin 3. As the regulators of Cten also seemed to regulate Tensin 3, we tested the interaction between Cten and Tensin 3. Cten was forcibly expressed or knocked down resulting, respectively, in upregulation and downregulation of Tensin 3. We conclude that in CRC, Cten is upregulated by EGFR and Kras but downregulated by STAT3. We show that calpain may be a negative regulator of Cten and that a Tensin switch does not occur and, if anything, Cten stabilizes Tensin 3.
© 2016 The Authors. International Journal of Experimental Pathology © 2016 International Journal of Experimental Pathology.

Entities:  

Keywords:  Cten; EGF; Kras; STAT3; Tensin 3; calpain

Mesh:

Substances:

Year:  2016        PMID: 26852686      PMCID: PMC4744826          DOI: 10.1111/iep.12154

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  28 in total

1.  Global alterations in mRNA polysomal recruitment in a cell model of colorectal cancer progression to metastasis.

Authors:  Alessandro Provenzani; Raffaele Fronza; Fabrizio Loreni; Alessia Pascale; Marialaura Amadio; Alessandro Quattrone
Journal:  Carcinogenesis       Date:  2006-03-10       Impact factor: 4.944

2.  Calpain-mediated proteolysis of paxillin negatively regulates focal adhesion dynamics and cell migration.

Authors:  Christa L Cortesio; Lindsy R Boateng; Timothy M Piazza; David A Bennin; Anna Huttenlocher
Journal:  J Biol Chem       Date:  2011-01-26       Impact factor: 5.157

3.  Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten.

Authors:  Isaia Barbieri; Sara Pensa; Tania Pannellini; Elena Quaglino; Diego Maritano; Marco Demaria; Alessandra Voster; James Turkson; Federica Cavallo; Christine J Watson; Paolo Provero; Piero Musiani; Valeria Poli
Journal:  Cancer Res       Date:  2010-03-09       Impact factor: 12.701

4.  Proteolytic cleavage of alpha-actinin by calpain in T cells stimulated with anti-CD3 monoclonal antibody.

Authors:  N Selliah; W H Brooks; T L Roszman
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

5.  The Tensin-3 protein, including its SH2 domain, is phosphorylated by Src and contributes to tumorigenesis and metastasis.

Authors:  Xiaolan Qian; Guorong Li; William C Vass; Alex Papageorge; Renard C Walker; Laura Asnaghi; Peter J Steinbach; Giovanna Tosato; Kent Hunter; Douglas R Lowy
Journal:  Cancer Cell       Date:  2009-09-08       Impact factor: 31.743

6.  Regulation of adhesion dynamics by calpain-mediated proteolysis of focal adhesion kinase (FAK).

Authors:  Keefe T Chan; David A Bennin; Anna Huttenlocher
Journal:  J Biol Chem       Date:  2010-02-11       Impact factor: 5.157

7.  Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice.

Authors:  Monica Musteanu; Leander Blaas; Markus Mair; Michaela Schlederer; Martin Bilban; Stefanie Tauber; Harald Esterbauer; Mathias Mueller; Emilio Casanova; Lukas Kenner; Valeria Poli; Robert Eferl
Journal:  Gastroenterology       Date:  2009-12-04       Impact factor: 22.682

8.  Up-regulation of C-terminal tensin-like molecule promotes the tumorigenicity of colon cancer through beta-catenin.

Authors:  Yi-Chun Liao; Nien-Tsu Chen; Yi-Ping Shih; Ying Dong; Su Hao Lo
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

9.  Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.

Authors:  R Seth; S Crook; S Ibrahem; W Fadhil; D Jackson; M Ilyas
Journal:  Gut       Date:  2009-05-26       Impact factor: 23.059

10.  The dark and the bright side of Stat3: proto-oncogene and tumor-suppressor.

Authors:  Andrea Ecker; Olivia Simma; Andrea Hoelbl; Lukas Kenner; Hartmut Beug; Richard Moriggl; Veronika Sexl
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more
  6 in total

1.  EGFRAP encodes a new negative regulator of the EGFR acting in both normal and oncogenic EGFR/Ras-driven tissue morphogenesis.

Authors:  Jennifer Soler Beatty; Cristina Molnar; Carlos M Luque; Jose F de Celis; María D Martín-Bermudo
Journal:  PLoS Genet       Date:  2021-08-19       Impact factor: 5.917

2.  Increased tensin 4 expression is related to the histological type of gastric cancer.

Authors:  Marcin Nizioł; Justyna Zińczuk; Konrad Zaręba; Katarzyna Guzińska-Ustymowicz; Anna Pryczynicz
Journal:  World J Clin Oncol       Date:  2021-12-24

3.  TGFβ1-induced cell motility but not cell proliferation is mediated through Cten in colorectal cancer.

Authors:  Abdulaziz Asiri; Teresa Pereira Raposo; Abdulaziz Alfahed; Mohammad Ilyas
Journal:  Int J Exp Pathol       Date:  2019-01-15       Impact factor: 1.925

4.  Calpain-2 inhibitor treatment preferentially reduces tumor progression for human colon cancer cells expressing highest levels of this enzyme.

Authors:  Michael P Marciel; Aaron H Rose; Verena Martinez; David T Horio; Ann S Hashimoto; FuKun W Hoffmann; Pietro Bertino; Peter R Hoffmann
Journal:  Cancer Med       Date:  2017-12-06       Impact factor: 4.452

5.  Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junction.

Authors:  Kenichi Aratani; Shuhei Komatsu; Daisuke Ichikawa; Takuma Ohashi; Mahito Miyamae; Wataru Okajima; Taisuke Imamura; Jun Kiuchi; Keiji Nishibeppu; Toshiyuki Kosuga; Hirotaka Konishi; Atsushi Shiozaki; Hitoshi Fujiwara; Kazuma Okamoto; Hitoshi Tsuda; Eigo Otsuji
Journal:  Oncotarget       Date:  2017-09-20

6.  Calpain system protein expression and activity in ovarian cancer.

Authors:  Siwei Zhang; Suha Deen; Sarah J Storr; Panagiota S Chondrou; Holly Nicholls; Anqi Yao; Ployphailin Rungsakaolert; Stewart G Martin
Journal:  J Cancer Res Clin Oncol       Date:  2018-11-17       Impact factor: 4.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.